ID   CCLF-NEURO-0108-T
AC   CVCL_D3YY
SY   CCLF_NEURO_0108_T; CCLF-KL1100T; CCLF_KL1100T; CPDM_0727X
DR   DSMZ; ACC-937
DR   Wikidata; Q127380427
WW   Provider; CPDM; CPDM_0727X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Group: Serum/protein free medium cell line.
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~4-5 days (DSMZ=ACC-937).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ile33Asn (c.98T>A); Zygosity=Homozygous (DSMZ=ACC-937).
CC   Sequence variation: Mutation; HGNC; HGNC:11098; SMARCA2; Simple; p.Asp1546Glu (c.4638C>G); ClinVar=VCV000126349; Zygosity=Homozygous (DSMZ=ACC-937).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (DSMZ=ACC-937).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, base of skull; UBERON=UBERON_0002517.
ST   Source(s): DSMZ=ACC-937
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 25
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 20,26
ST   Penta D: 12,13
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 14,15
DI   NCIt; C3904; Papillary meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//